EP1636341A4 - Stammzellen für klinische und kommerzielle anwendungen - Google Patents

Stammzellen für klinische und kommerzielle anwendungen

Info

Publication number
EP1636341A4
EP1636341A4 EP04809422A EP04809422A EP1636341A4 EP 1636341 A4 EP1636341 A4 EP 1636341A4 EP 04809422 A EP04809422 A EP 04809422A EP 04809422 A EP04809422 A EP 04809422A EP 1636341 A4 EP1636341 A4 EP 1636341A4
Authority
EP
European Patent Office
Prior art keywords
clinical
stem cells
commercial uses
commercial
stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04809422A
Other languages
English (en)
French (fr)
Other versions
EP1636341A2 (de
Inventor
Liping Tang
Robert H Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/857,443 external-priority patent/US20050014255A1/en
Application filed by University of Texas System filed Critical University of Texas System
Publication of EP1636341A2 publication Critical patent/EP1636341A2/de
Publication of EP1636341A4 publication Critical patent/EP1636341A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP04809422A 2003-05-29 2004-05-28 Stammzellen für klinische und kommerzielle anwendungen Withdrawn EP1636341A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47402003P 2003-05-29 2003-05-29
US10/857,443 US20050014255A1 (en) 2003-05-29 2004-05-27 Stem cells for clinical and commercial uses
PCT/US2004/017009 WO2005033268A2 (en) 2003-05-29 2004-05-28 Stem cells for clinical and commercial uses

Publications (2)

Publication Number Publication Date
EP1636341A2 EP1636341A2 (de) 2006-03-22
EP1636341A4 true EP1636341A4 (de) 2007-08-01

Family

ID=46123777

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04809422A Withdrawn EP1636341A4 (de) 2003-05-29 2004-05-28 Stammzellen für klinische und kommerzielle anwendungen

Country Status (4)

Country Link
EP (1) EP1636341A4 (de)
JP (1) JP2007525193A (de)
CA (1) CA2527700A1 (de)
WO (1) WO2005033268A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8465976B2 (en) 2007-02-12 2013-06-18 Cedars-Sinai Medical Center Methods for isolating and using hematopoietic and embryonic stem cells of the peritoneal cavity
KR20100039284A (ko) * 2007-05-21 2010-04-15 웨이크 포리스트 유니버시티 헬스 사이언시즈 소변으로부터의 전구 세포 및 이를 사용하는 방법
WO2010065239A1 (en) 2008-12-05 2010-06-10 Wake Forest University Health Sciences Stem cells from urine and methods for using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046373A1 (en) * 2000-12-06 2002-06-13 Hariri Robert J Method of collecting placental stem cells
WO2004024957A2 (en) * 2002-09-12 2004-03-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for detection of micro-metastasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
ES2292245T3 (es) * 1998-05-29 2008-03-01 Osiris Therapeutics, Inc. Celulas madre mesenquimaticas cd45+ y/o fibroblasto+humanas.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046373A1 (en) * 2000-12-06 2002-06-13 Hariri Robert J Method of collecting placental stem cells
WO2004024957A2 (en) * 2002-09-12 2004-03-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for detection of micro-metastasis

Also Published As

Publication number Publication date
WO2005033268A8 (en) 2005-06-02
WO2005033268A9 (en) 2005-09-15
WO2005033268A3 (en) 2006-03-23
CA2527700A1 (en) 2005-04-14
JP2007525193A (ja) 2007-09-06
WO2005033268A2 (en) 2005-04-14
EP1636341A2 (de) 2006-03-22

Similar Documents

Publication Publication Date Title
EP1689854A4 (de) Plazentastammzellen und verwendungen davon
GB0329449D0 (en) Stem cells
GB2407821B (en) Stem Cells
AU2003247514A8 (en) Meningeal-derived stem cells
GB2441530B (en) Stem Cells
AU2003239159A8 (en) Placental derived stem cells and uses thereof
EP1809740A4 (de) Herzstammzellen
GB0113118D0 (en) Stem Cells
GB2414480B (en) Directed genetic modifications of human stem cells
AU2003294246A8 (en) Circulating stem cells and uses related thereto
EP1627912A4 (de) Herstellung endodermaler stammzellen
AU2003224702A8 (en) Stem cell selection and differentiation
AU2003216822A8 (en) Stem cell culture
EP1554373A4 (de) Zur kultivierung von stammzellen geeignete menschliche vorhautzellen
EP1637589A4 (de) Neue, von adultem gewebe abgeleitete stammzelle und deren verwendung
EP1581637A4 (de) Materialien und verfahren mit menschlichen stammzellen
HK1126815A1 (en) Entrapped stem cells and uses thereof
AU2003284314A8 (en) Stem cell populations
EP1685237A4 (de) Neue multipotente stammzellen und verwendung davon
EP1636341A4 (de) Stammzellen für klinische und kommerzielle anwendungen
GB0207299D0 (en) Stem cell therapy
SI1781775T1 (sl) Vaskularne matične celice in njihove uporabe
GB0328943D0 (en) Differentiated cells
EP1563073A4 (de) Proteinproduktionsverfahren und modifizierte zellen zur verwendung darin
GB0219544D0 (en) Cell Culture

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051222

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL HR LT LV MK

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/00 20060101AFI20060427BHEP

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070628

17Q First examination report despatched

Effective date: 20080317

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080930